Prevalence of drug-drug interactions in geriatric patients at an ambulatory care pharmacy in a tertiary care teaching hospital

被引:21
|
作者
Aljadani R. [1 ]
Aseeri M. [1 ,2 ]
机构
[1] Pharmacy Department, King Saud Bin AbdulAziz University for Health Sciences, King AbdulAziz Medical City, Riyadh
[2] Clinical Pharmacy Services, Pharmacy Department, King Saud Bin AbdulAziz University for Health Sciences, King AbdulAziz Medical City, PO Box 9515, Jeddah
关键词
Ambulatory care; Drug-drug interactions; Geriatric; Pharmacy; Prevalence;
D O I
10.1186/s13104-018-3342-5
中图分类号
学科分类号
摘要
Objective: A cross-sectional study was performed from February to May 2015, to estimate the prevalence of drug-drug interactions in geriatric patients at the ambulatory care pharmacy at King Abdul-Aziz Medical City in Jeddah, Saudi Arabia. Results: A total of 310 patients were included, with a mean age (± SD) of 73.78 ± 6.96, and 48.70% were female. The overall prevalence of DDIs of all categories was 90.64%. Category B DDIs was 55.80%, category C DDIs 87.74%, category D DDIs 51.93%, and category X DDIs 16.45%. Atorvastatine plus omeprazole was identified as the most common interacting pair, with a prevalence of 25.26%. Multivariate logistic regression analysis showed that category D or X DDIs are more likely to occur in the female patient (OR = 1.79; 95% CI 1.07, 2.97), the patient taking more than three medications (OR = 22.62; 95% CI 2.93, 174.83), and the patient with more than two conditions (OR = 3.09; 95% CI 1.81, 5.27). © 2018 The Author(s).
引用
收藏
相关论文
共 50 条
  • [21] Drug-Drug Interactions with Oral Anticoagulants as Potentially Inappropriate Medications: Prevalence and Outcomes in Elderly Patients in Primary Care and Hospital Settings
    Bories, Mathilde
    Bouzille, Guillaume
    Cuggia, Marc
    Le Corre, Pascal
    PHARMACEUTICS, 2022, 14 (07)
  • [22] Prevalence and associated factors of drug-drug interactions in elderly outpatients in a tertiary care hospital: a cross-sectional study based on three databases
    Liu, Yue
    Wang, Jin
    Gong, Hui
    Li, Chen
    Wu, Jin
    Xia, Tianyi
    Li, Chuntong
    Li, Shu
    Chen, Mengli
    ANNALS OF TRANSLATIONAL MEDICINE, 2023,
  • [23] Impact of the drug-drug interaction database SFINX on prevalence of potentially serious drug-drug interactions in primary health care
    M. L. Andersson
    Y. Böttiger
    J. D. Lindh
    B. Wettermark
    B. Eiermann
    European Journal of Clinical Pharmacology, 2013, 69 : 565 - 571
  • [24] Impact of the drug-drug interaction database SFINX on prevalence of potentially serious drug-drug interactions in primary health care
    Andersson, M. L.
    Bottiger, Y.
    Lindh, J. D.
    Wettermark, B.
    Eiermann, B.
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2013, 69 (03) : 565 - 571
  • [25] Potential drug-drug interactions in cardiology ward of a teaching hospital
    Ismail, Mohammad
    Iqbal, Zafar
    Khattak, Muhammad Bilal
    Khan, Muhammad Imran
    Javaid, Arshad
    Khan, Tahir Mehmood
    HEALTHMED, 2012, 6 (05): : 1618 - 1624
  • [26] Prevalence of drug-drug interactions at hospital entry and during hospital stay of patients in internal medicine
    Vonbach, Priska
    Dubied, Andre
    Kraehenbuehl, Stephan
    Beer, Juerg H.
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2008, 19 (06) : 413 - 420
  • [27] Severity and Management of Drug-Drug Interactions in Acute Geriatric Patients
    Lea, Marianne
    Rognan, Stine Eidhammer
    Koristovic, Radojka
    Wyller, Torgeir Bruun
    Molden, Espen
    DRUGS & AGING, 2013, 30 (09) : 721 - 727
  • [28] The Prevalence and Severity of Potential Drug-Drug Interactions in Internal Medicine Ward at Soba Teaching Hospital
    Hamadouk, Riham M.
    Alshareif, Einass Mahmoud
    Hamad, Huda M.
    Yousef, Bashir A.
    DRUG HEALTHCARE AND PATIENT SAFETY, 2023, 15 : 149 - 157
  • [29] Prevalence and predictors of potential drug-drug interactions
    Nikolic, Bozana
    Jankovic, Slobodan
    Stojanov, Oliver
    Popovic, Jovan
    CENTRAL EUROPEAN JOURNAL OF MEDICINE, 2014, 9 (02): : 348 - 356
  • [30] Drug-drug interactions in the intensive care unit: Do they really matter?
    Vanham, D.
    Spinewine, A.
    Hantson, Ph.
    Wittebole, X.
    Wouters, D.
    Sneyers, B.
    JOURNAL OF CRITICAL CARE, 2017, 38 : 97 - 103